Needham Downgrades Amphastar Pharma to Hold

Benzinga Newsdesk www.benzinga.com Negative 87.5%

Neg 87.5% Neu 0% Pos 0%

Needham analyst Serge Belanger downgrades Amphastar Pharma (NASDAQ:AMPH) from Buy to Hold.

Comments

No comments yet. Be the first!